{"id":"W4385698344","doi":"10.1097/01.hs9.0000971164.88567.72","title":"P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN USED IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PD-1–REFRACTORY CLASSICAL HODGKIN LYMPHOMA","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Refractory (planetary science); Medicine; Internal medicine; Oncology; Lymphoma; Phases of clinical research; Clinical trial; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00538596,0.0005258254,0.002379139,0.0007439889,0.0002262406,0.0009401427,0.0005005469,0.0008597686,0.001782495],"category_scores_gemma":[0.005505628,0.0002978917,0.002511111,0.000683097,0.0004179151,0.001020692,0.000395388,0.001197136,0.000517615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007981129,"about_ca_system_score_gemma":0.0003726139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000203093,"about_ca_topic_score_gemma":0.0003615389,"domain_scores_codex":[0.9968296,0.001748128,0.0003934439,0.0003882239,0.0004862314,0.0001543216],"domain_scores_gemma":[0.9954036,0.002824704,0.001004279,0.000215741,0.0002250374,0.0003267134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5069296,0.002532566,0.2936474,0.002836758,0.01539992,0.0003495428,0.000334031,0.005269027,0.01908352,0.0002596655,0.001190265,0.1521676],"study_design_scores_gemma":[0.03800453,0.3143056,0.5883482,0.0003946563,0.01959915,0.001623983,0.0003807545,0.01143772,0.01557577,0.0007324964,0.009435073,0.0001620375],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896092,0.00707346,0.0004669296,0.0001689002,0.00008504497,0.0002984026,0.000695671,0.00002793001,0.001574484],"genre_scores_gemma":[0.9977477,0.0005612472,0.0005618839,0.0001070192,0.00008890618,0.0001629049,0.0004919898,0.000007622254,0.0002707889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00538596,"threshold_uncertainty_score":0.02848405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01465067494179615,"score_gpt":0.2512173056998726,"score_spread":0.2365666307580765,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}